The Saudi Food and Drug Authority (SFDA) released a Safety Communication on 23 July 2025 highlighting the risk of weight loss and growth suppression in… Read More »SFDA: Paediatric Weight Loss Risk with Extended Release Stimulants
Perhaps as a result of the stereotype of ADHD being that of a disruptive young boy, ADHD is thought to be under-recognised in girls and women.… Read More »ADHD diagnosis and treatment in women
The World Health Organisation has rejected another attempt to have Methylphenidate (MPH) added to the Essential Medicines List (EML).
In the meeting of the Saudi ADHD Society’s Psychological and Medical Committee held on 7 September 2023, the following minor updates to the Saudi ADHD… Read More »CPG Minor Update 2023
To improve the quality of health care for people with autism, the Saudi Health Council issued the Evidence-Based Guideline for autism in July 2023.
In the meeting of the Saudi ADHD Society’s Psychological and Medical Committee held on 15 Dec 2022, the following minor updates to the Saudi ADHD… Read More »CPG Minor Update 2022
In Saudi Arabia the terms “Hyperkinetic” and “Disturbance of activity and attention” are still in use for clinical coding purposes, since Saudi Arabia uses the… Read More »Preparations for ICD-11
We’re pleased to announce that the Evidence-based clinical practice guideline for Management of Attention Deficit Hyperactivity Disorder (ADHD) in Saudi Arabia has been registered with… Read More »IPGRP Registration
As part of the 5th International Psychiatry Conference organised by King Saud University, a workshop was conducted to assess the quality of CPGs for people… Read More »AGREE-REX Workshop
The Evidence-Based Clinical Practice Guideline for Management of ADHD in the Kingdom of Saudi Arabia was launched under the patronage of H.E. the Minister of… Read More »CPG Launch Ceremony
